These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 37679630)

  • 21. Affibody Molecules as Targeting Vectors for PET Imaging.
    Tolmachev V; Orlova A
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32168760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineered Protein Scaffolds as Next-Generation Therapeutics.
    Gebauer M; Skerra A
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():391-415. PubMed ID: 31914898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploiting next-generation sequencing in antibody selections - a simple PCR method to recover binders.
    Ferrara F; Teixeira AA; Naranjo L; Erasmus MF; D'Angelo S; Bradbury ARM
    MAbs; 2020; 12(1):1701792. PubMed ID: 31829073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-throughput retrieval of physical DNA for NGS-identifiable clones in phage display library.
    Noh J; Kim O; Jung Y; Han H; Kim JE; Kim S; Lee S; Park J; Jung RH; Kim SI; Park J; Han J; Lee H; Yoo DK; Lee AC; Kwon E; Ryu T; Chung J; Kwon S
    MAbs; 2019 Apr; 11(3):532-545. PubMed ID: 30735467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bispecific applications of non-immunoglobulin scaffold binders.
    Hober S; Lindbo S; Nilvebrant J
    Methods; 2019 Feb; 154():143-152. PubMed ID: 30287281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Next-Generation Sequencing of Antibody Display Repertoires.
    Rouet R; Jackson KJL; Langley DB; Christ D
    Front Immunol; 2018; 9():118. PubMed ID: 29472918
    [No Abstract]   [Full Text] [Related]  

  • 27. Affibody Molecules in Biotechnological and Medical Applications.
    Ståhl S; Gräslund T; Eriksson Karlström A; Frejd FY; Nygren PÅ; Löfblom J
    Trends Biotechnol; 2017 Aug; 35(8):691-712. PubMed ID: 28514998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Affibody-Auristatin E Conjugate With a Potent and Selective Activity Against HER2+ Cell Lines.
    Sochaj-Gregorczyk AM; Serwotka-Suszczak AM; Otlewski J
    J Immunother; 2016; 39(6):223-32. PubMed ID: 27227324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigating affinity-maturation strategies and reproducibility of fluorescence-activated cell sorting using a recombinant ADAPT library displayed on staphylococci.
    Åstrand M; Nilvebrant J; Björnmalm M; Lindbo S; Hober S; Löfblom J
    Protein Eng Des Sel; 2016 May; 29(5):187-95. PubMed ID: 26984961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges and opportunities for non-antibody scaffold drugs.
    Vazquez-Lombardi R; Phan TG; Zimmermann C; Lowe D; Jermutus L; Christ D
    Drug Discov Today; 2015 Oct; 20(10):1271-83. PubMed ID: 26360055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitive recovery of recombinant antibody clones after their in silico identification within NGS datasets.
    Spiliotopoulos A; Owen JP; Maddison BC; Dreveny I; Rees HC; Gough KC
    J Immunol Methods; 2015 May; 420():50-5. PubMed ID: 25771970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo biotinylation and incorporation of a photo-inducible unnatural amino acid to an antibody-binding domain improve site-specific labeling of antibodies.
    Kanje S; Hober S
    Biotechnol J; 2015 Apr; 10(4):564-74. PubMed ID: 25655274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An affibody-adalimumab hybrid blocks combined IL-6 and TNF-triggered serum amyloid A secretion in vivo.
    Yu F; Gudmundsdotter L; Akal A; Gunneriusson E; Frejd F; Nygren PÅ
    MAbs; 2014; 6(6):1598-607. PubMed ID: 25484067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering of a bispecific affibody molecule towards HER2 and HER3 by addition of an albumin-binding domain allows for affinity purification and in vivo half-life extension.
    Malm M; Bass T; Gudmundsdotter L; Lord M; Frejd FY; Ståhl S; Löfblom J
    Biotechnol J; 2014 Sep; 9(9):1215-22. PubMed ID: 24678002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical synthesis of triple-labelled three-helix bundle binding proteins for specific fluorescent detection of unlabelled protein.
    Engfeldt T; Renberg B; Brumer H; Nygren PA; Karlström AE
    Chembiochem; 2005 Jun; 6(6):1043-50. PubMed ID: 15880677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain.
    Nord K; Gunneriusson E; Ringdahl J; Ståhl S; Uhlén M; Nygren PA
    Nat Biotechnol; 1997 Aug; 15(8):772-7. PubMed ID: 9255793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A synthetic IgG-binding domain based on staphylococcal protein A.
    Nilsson B; Moks T; Jansson B; Abrahmsén L; Elmblad A; Holmgren E; Henrichson C; Jones TA; Uhlén M
    Protein Eng; 1987; 1(2):107-13. PubMed ID: 3507693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of Affibody Affinity Proteins from Phagemid Libraries.
    Giang KA; Nygren PÅ; Nilvebrant J
    Methods Mol Biol; 2023; 2702():373-392. PubMed ID: 37679630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteriophage vehicles for phage display: biology, mechanism, and application.
    Ebrahimizadeh W; Rajabibazl M
    Curr Microbiol; 2014 Aug; 69(2):109-20. PubMed ID: 24638925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular considerations for development of phage antibody libraries.
    Tohidkia MR; Barar J; Asadi F; Omidi Y
    J Drug Target; 2012 Apr; 20(3):195-208. PubMed ID: 21950316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.